“Market Access is a complex field that cannot be restricted to health economics, pricing or comparative effectiveness. Teaching Market Access needs to respond to an increasing demand for knowledge and expertise by pharma companies that now have to integrate the process early in the development strategy of a drug or device.”
“Companies need efficient methods for analyzing the market and taking adequate decisions in an uncertain and complex competitive environment. The European Market Access University Diploma provides expertise in Market Access decision making.”